Health and Wellness

CVS Health Path Forward Becomes Clearer And Breakup Is Unlikely

Cold Water on CVS Health Breakup Rumors: CEO David Joyner Commits to Improving Diversified Portfolio In his first earnings call following a quarterly earnings report, CEO David Joyner gave no

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

Researchers Begin Developing Ovarian Cancer Vaccine

Researchers in the United Kingdom have recently received a significant funding boost to develop the world's first vaccine for ovarian

The Senate must pass the Access to AEDs Act

Damar Hamlin, a starting safety for the Buffalo Bills, has been making headlines for his impressive performance on the field,

US adults in worse health than British counterparts at midlife, finds study

A recent study published in the International Journal of Epidemiology has revealed that American adults in midlife have significantly worse

Biden Administration Issues Rules To Ensure Parity In Mental Health Coverage

President Joe Biden recently announced a groundbreaking proposal aimed at improving access to mental healthcare for millions of Americans. The

Rollout of new tools to curb RSV expected to be smoother this year

For Beyfortus, the timing is also crucial. The injection has to be given to infants before their first RSV season,

Federal government may be paying twice for care of veterans enrolled in Medicare Advantage plans

The Veterans Health Administration has spent $78 billion from 2011 to 2020 on U.S. military veterans enrolled in Medicare Advantage

The Prototype: Cloning Big Game Animals

The latest edition of The Prototype delves into a variety of fascinating topics, from cloning animals for hunting to the

Trump policy on drug pricing: Abandons most favored nations idea

Former President Trump has recently shifted his stance on a controversial drug pricing plan that caused concern among pharmaceutical executives